Mother-to-infant transmission of HIV-1: The placenta fights back

Journal of Clinical Investigation

Volumn 107, Issue 3, 2001, Pages 267-269

  Spector, S A ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FETOMATERNAL TRANSFUSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; PLACENTA; PRIORITY JOURNAL; VIRUS TRANSMISSION;

EID: 0035132650     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI12094     Document Type: Note

References (21)

1. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
2. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus
3. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyper-immune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: Results of Pediatric AIDS Clinical Trials Group protocol 185
4. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators
5. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
6. Global summary of the HIV/AIDS epidemic update: December 1998
7. Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women
8. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor
9. Localization of leukemia inhibitory factor and its receptor in human placenta throughout pregnancy
10. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
11. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
12. Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5-delta-32ccr5 heterozygotes
13. The CCR5Δ allele slows disease progression of human immunodeficiency virus (HIV) type-1 infected children receiving anti-retroviral treatment
14. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants
15. Maternal SDF1 3′A polymorphism is associated with increased perinatal human immunodeficiency virus type 1 transmission
16. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission
17. Clinical significance of human immunodeficiency virus type 1 phenotypes in infected children
18. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants
19. Human chorionic gonadotropin hormone prevents wasting syndrome and death in HIV-1 transgenic mice
20. Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype
21. HIV in infants and children: Transmission and progression